ULTRAGENYX PHARMACEUTICAL INC. Common Stock, Par or Stated Value Per Share
ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Common Stock, Par or Stated Value Per Share of $0.00 per share as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockParOrStatedValuePerShare · last filed 2026-08-05
- 2026-06-30: Common Stock, Par or Stated Value Per Share $0.00.
- 2026-03-31: Common Stock, Par or Stated Value Per Share $0.00.
- 2025-12-31: Common Stock, Par or Stated Value Per Share $0.00.
- 2025-09-30: Common Stock, Par or Stated Value Per Share $0.00.
| Period end | Common Stock, Par or Stated Value Per Share |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-05 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-18 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-02 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-03 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-19 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-21 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-17 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-15 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-12 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-14 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-20 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-21 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-17 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-10 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-14 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-12 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-26 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-10 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-11 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |